These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2192714)

  • 1. [Molecular nature of oncogene HRAS1 damage in human breast carcinoma: G----T transversion in codon 12 of one allele during deletion of other allele].
    Kniazev PG; Serova OM; Babenko VI; Nikiforova IF; Gol'tseva AA; Pluzhnikova GF; Plutalov OV; Berlin IuA; Shvarts EI
    Bioorg Khim; 1990 Mar; 16(3):419-23. PubMed ID: 2192714
    [No Abstract]   [Full Text] [Related]  

  • 2. [A molecular genetic analysis of the 12th codon of the Ha-ras-1 proto-oncogene in human carcinoma and stomach ulcer cells].
    Novikov LB; Fedorov SN; Iatsuk OS; Kalinovskiĭ VP; Tlevlesov NIa; Levanova GI; Matveev BV; Mel'nikov RA; Seĭts IF
    Eksp Onkol; 1990; 12(2):58-9. PubMed ID: 2180677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
    Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
    Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
    Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR
    Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
    Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
    Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
    Shan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells.
    Zhang PL; Calaf G; Russo J
    Mol Carcinog; 1994 Jan; 9(1):46-56. PubMed ID: 8297485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
    Vachtenheim J; Horáková I; Novotná H
    Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent p53 gene mutations and novel alleles in familial breast cancer.
    Glebov OK; McKenzie KE; White CA; Sukumar S
    Cancer Res; 1994 Jul; 54(14):3703-9. PubMed ID: 8033087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low incidence of point mutation of N-ras oncogene in human gliomas].
    Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
    No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
    Kumar R; Angelini S; Hemminki K
    Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
    Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
    Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.